Could depression change how Kids' asthma responds to treatment?

NCT ID NCT04617015

Completed Knowledge-focused Sponsor: State University of New York at Buffalo Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at 39 children with asthma to see if those with depression have a different type of airway response. Researchers tested whether an anticholinergic inhaler (ipratropium) works better in depressed versus non-depressed children. The goal was to better understand this possible asthma subtype, not to test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Ipratropium Bromide (an anticholinergic inhaler)
What this could lead to: If successful, this could point toward a personalized treatment approach for children with asthma and depression, using a different type of inhaler.
What could go wrong: This is a very small, early-phase study with only 39 participants. It is designed to gather information, not to prove a treatment works. Results may not apply to all children with asthma and depression.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

asthma childhood onset asthma Depression depressive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ASTHMA CHILDHOOD ASTHMA DEPRESSION

Contacts and locations

Locations

Women and Children's Hospital of Buffalo

Buffalo, New York, 14222, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.